Aging Faster Than Your Years: The Science of HIV-Driven Biological Aging and How to Fight Back

For millions of Americans living with HIV, antiretroviral therapy (ART) has rewritten what a diagnosis means. Where HIV once carried a devastating prognosis, it now allows people to live for decades — often into older adulthood. That progress is extraordinary and worth celebrating. Yet a quieter, more complex story is unfolding in clinics and research laboratories across the country: even with viral loads suppressed to undetectable levels, HIV appears to accelerate the biological aging process in ways that chronological age alone does not capture.

This is not a reason for alarm. It is, however, a reason for awareness — and for proactive, informed conversations with your care team.

What Do We Mean by 'Biological Aging'?

Chronological age is simply how many years you have been alive. Biological age, by contrast, reflects the functional state of your cells, tissues, and organ systems. Researchers measure it through tools like epigenetic clocks — molecular markers embedded in DNA that track how cells have accumulated wear over time. Studies using these clocks have consistently found that people living with HIV often show biological ages meaningfully older than their birth certificates would suggest, sometimes by a decade or more.

This gap exists even among individuals who have been on effective ART for years. The implication is significant: the body may be experiencing stress that standard bloodwork and routine checkups do not fully capture.

The Engine Behind Early Aging: Inflammaging

At the center of this phenomenon is a process researchers call inflammaging — a portmanteau of inflammation and aging. Under normal circumstances, the immune system mounts an inflammatory response to fight infection, then stands down when the threat is resolved. HIV disrupts this cycle.

Even when the virus is suppressed, the immune system remains in a state of chronic, low-grade activation. Residual HIV reservoirs — dormant viral particles hiding in immune cells — continue to trigger subtle immune responses. Additionally, the gut lining, which HIV damages early in infection, can become more permeable, allowing bacterial products to leak into the bloodstream and sustain systemic inflammation over time.

This persistent inflammatory state is not benign. Over years and decades, it accelerates cellular damage in the same way that chronic stress corrodes machinery — gradually, cumulatively, and across multiple systems simultaneously.

Which Organ Systems Are Most Affected?

Bones: People living with HIV experience higher rates of low bone mineral density and osteoporosis compared to HIV-negative peers of the same age. Inflammation interferes with the balance between bone-building and bone-resorbing cells, while certain older antiretroviral medications — particularly tenofovir disoproxil fumarate — have also been associated with reduced bone density. Fractures that might be considered an older adult's concern can arrive earlier for those living with HIV.

Kidneys: Chronic inflammation contributes to accelerated kidney aging. HIV itself can directly infect kidney cells, and some antiretroviral agents carry nephrotoxic potential. Monitoring kidney function through regular creatinine and estimated glomerular filtration rate (eGFR) testing is therefore a cornerstone of HIV primary care.

The Brain and Cognitive Function: Even with viral suppression, neuroinflammation can persist. Some long-term survivors report difficulties with memory, processing speed, and executive function — collectively described as HIV-associated neurocognitive disorders (HAND). The spectrum ranges from mild and barely noticeable to more disruptive. Early identification through cognitive screening allows for timely support and intervention.

Cardiovascular Health: Chronic inflammation accelerates atherosclerosis — the buildup of plaques in arterial walls — at rates that exceed what traditional cardiovascular risk factors like smoking or cholesterol alone would predict. People living with HIV face a measurably elevated risk of heart attack and stroke, making cardiovascular screening a non-negotiable component of long-term care.

Immune Resilience: The immune system itself ages faster in the context of HIV. CD4 T-cell counts may recover substantially on ART, but the functional diversity and responsiveness of the immune repertoire can be diminished. This affects not only susceptibility to opportunistic infections but also the robustness of responses to vaccines — a practical consideration for annual flu shots, COVID-19 boosters, shingles vaccines, and beyond.

Screening Timelines Worth Knowing

Because age-related complications may arrive earlier than expected, the standard preventive care timelines designed for the general population may not be sufficient. Discussing the following with your HIV specialist or primary care provider is worthwhile:

• Bone density (DEXA scan): Many guidelines recommend baseline screening for people living with HIV at age 50, though some clinicians advocate for earlier assessment based on individual risk.
• Kidney function: Annual monitoring of eGFR and urine protein is standard practice in HIV care.
• Cardiovascular risk: Annual lipid panels and a formal cardiovascular risk calculation (such as the ACC/AHA Pooled Cohort Equations) help identify those who may benefit from statins or other interventions.
• Cognitive screening: Brief validated tools administered periodically can detect subtle changes before they become disruptive.
• Cancer screening: Certain malignancies — including anal cancer, lung cancer, and liver cancer — occur at higher rates and sometimes earlier in people living with HIV. Discuss individualized screening schedules with your provider.

Lifestyle Interventions That Shift the Trajectory

The science of inflammaging, while sobering, also points toward meaningful opportunities for intervention. Several lifestyle factors directly modulate inflammatory pathways.

Physical activity is among the most potent anti-inflammatory tools available. Regular aerobic exercise — even brisk walking for 30 minutes most days — has been shown to reduce systemic inflammatory markers, support bone density, and improve cardiovascular and cognitive outcomes. Resistance training adds further benefit for bone and muscle mass.

Diet matters considerably. An anti-inflammatory dietary pattern — rich in vegetables, fruits, whole grains, legumes, fatty fish, and olive oil, and low in ultra-processed foods and added sugars — is associated with reduced inflammatory burden. The Mediterranean diet, in particular, has been studied in the context of HIV and shows favorable associations with cardiovascular and metabolic outcomes.

Sleep quality is frequently underestimated. Inadequate or disrupted sleep independently elevates inflammatory markers. People living with HIV experience higher rates of sleep disturbances; addressing these — whether through sleep hygiene improvements, screening for sleep apnea, or mental health support — is a legitimate and impactful clinical priority.

Smoking cessation is perhaps the single most impactful modifiable risk factor for people living with HIV. Smoking dramatically amplifies cardiovascular and pulmonary risk in an already-vulnerable population, and quitting at any age yields measurable benefit.

Alcohol moderation reduces both liver stress and systemic inflammation, while also supporting medication adherence — a cornerstone of sustained viral suppression.

The Conversation to Have With Your Care Team

Armed with this knowledge, consider scheduling a dedicated visit — or carving out time within your next appointment — to discuss biological aging and long-term health planning explicitly. Useful questions include:

• Based on my age and history, which organ systems should we be monitoring most closely?
• Am I on an ART regimen that minimizes long-term organ stress while maintaining full suppression?
• What is my calculated cardiovascular risk, and are there steps I should be taking now?
• Should I have a bone density scan?
• Are there cognitive screening tools you use, and when would you recommend one for me?

Modern HIV care increasingly recognizes that managing the virus is only one dimension of the job. Managing the body's long-term response to years of immune activation — and positioning patients to age as well as possible — is equally important.

A Framework for the Long Game

Living well with HIV across decades requires a long-game mindset. The research on biological aging is not a verdict; it is a map. It tells us where vulnerabilities are likely to emerge, which gives us the opportunity to intervene before damage accumulates to a clinically significant level.

The combination of effective ART, informed preventive screening, and sustained lifestyle investment represents the most powerful toolkit currently available. For people living with HIV in the United States today, the goal is not simply more years of life — it is more healthy, functional, and engaged years. The science of inflammaging, understood clearly and acted upon early, makes that goal more achievable than ever.